Macroview Investment Management’s Idexx Laboratories IDXX Stock Holding History

Macroview Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12	Closed	-$6.06K	–	295
2024 Q3	$6.06K	Hold	12	–	–	0.01%	338
2024 Q2	$5.85K	Hold	12	–	–	0.01%	347
2024 Q1	$6.48K	Hold	12	–	–	0.01%	364
2023 Q4	$6.66K	Hold	12	–	–	0.01%	355
2023 Q3	$5.25K	Sell	12 -2	-14%	-$997	0.01%	414
2023 Q2	$7.03K	Hold	14	–	–	0.01%	303
2023 Q1	$7K	Hold	14	–	–	0.01%	291
2022 Q4	$5.71K	Hold	14	–	–	0.01%	303
2022 Q3	$5K	Hold	14	–	–	0.01%	287
2022 Q2	$5K	Buy	14 +12	+600%	+$4.89K	0.01%	314
2022 Q1	$1K	Hold	2	–	–	﹤0.01%	382
2021 Q4	$1K	Hold	2	–	–	﹤0.01%	351
2021 Q3	$1K	Hold	2	–	–	﹤0.01%	342
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	368
2021 Q1	$1K	Hold	2	–	–	﹤0.01%	343
2020 Q4	$1K	Hold	2	–	–	﹤0.01%	319
2020 Q3	$1K	Buy	+2	New	+$739	﹤0.01%	295

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macroview Investment Management's IDXX Position: Q4 2024 in Review

Macroview Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 12 shares — an estimated $6.06K sold.

Macroview Investment Management first reported a position in IDXX in Q3 2020 and held it in 17 quarters. The position peaked at $7.03K in Q2 2023. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Macroview Investment Management reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Macroview Investment Management sold 12 Idexx Laboratories shares in Q4 2024, an estimated $6.06K.
Macroview Investment Management first reported a position in Idexx Laboratories in Q3 2020 and held it in 17 quarters.
Macroview Investment Management's Idexx Laboratories position peaked at $7.03K in Q2 2023.
1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.